Presentation TCT 2015 Which Patients for TAVR? Will Surgical Risk Stratification Remain the Dominant Strategy in the Future? Presenter: John G. Webb October 11, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study Presenter: Piotr Musialek October 13, 2015 More slides + Presentation TCT 2015 TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial Presenter: Nirat Beohar October 13, 2015 Presentation TCT 2015 Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease Presenter: Jan Sloves October 14, 2015 We Recommend
Presentation TCT 2015 TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study Presenter: Piotr Musialek October 13, 2015
Presentation TCT 2015 TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial Presenter: Nirat Beohar October 13, 2015
Presentation TCT 2015 Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease Presenter: Jan Sloves October 14, 2015